Skorska Malvina N, Saokhieo Pongpun, Thurston Lindsey T, Coome Lindsay A, Kaewthip Oranitcha, Chariyalertsak Suwat, VanderLaan Doug P
Child and Youth Psychiatry, Centre for Addiction and Mental Health, Toronto, Canada.
Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Transgend Health. 2024 Dec 16;9(6):516-521. doi: 10.1089/trgh.2022.0087. eCollection 2024 Dec.
This study describes Thai transfeminine individuals' exogenous hormone use.
During the period May-July 2017, a survey was conducted among Thai transfeminine adults (=181) who reported their exogenous hormone use, age at onset of use, brands used, where they obtained hormones, and discontinuation of use.
Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%).
Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.
本研究描述了泰国跨性别女性个体的外源激素使用情况。
在2017年5月至7月期间，对181名报告了其外源激素使用情况、开始使用的年龄、使用的品牌、获取激素的地点以及停止使用情况的泰国成年跨性别女性进行了一项调查。
大多数参与者（86.74%）使用外源激素。开始使用的平均（标准差）年龄为16.59（3.79）岁。使用了1至15个品牌，化学成分各不相同。激素通常从药店购买（91.39%），很少由医生开处方（8.61%）。停用6个月或更长时间很常见（59.62%）。
需要为泰国跨性别女性个体从青春期开始提供性别肯定性医疗保健。
